Vaxart, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 0.675 million compared to USD 0.085 million a year ago. Net loss was USD 25.14 million compared to USD 25.1 million a year ago.

Basic loss per share from continuing operations was USD 0.19 compared to USD 0.2 a year ago.